PRNewswire 4 June 2013
Riverside Partners, a Boston-based private equity firm, is pleased to announce that it has completed an investment in BioAgilytix Labs, a leading contract bioanalytical laboratory specializing in large molecule biologic drugs. Riverside Partners’ investment was completed in partnership with the BioAgilytix Founders and management team.
Headquartered in Research Triangle Park, North Carolina, BioAgilytix provides outsourced laboratory services to customers within the pharmaceutical, biotechnology, and agriculture industries. By developing, optimizing and conducting bioanalytic testing, the Company offers its customers a high-quality outsourcing option, which supports drug discovery, pre-clinical and clinical development, and manufacturing.
“The BioAgilytix team is very excited work with Riverside Partners. The Riverside team has a great understanding of how to scale a pharmaceutical services business, and the two organizations have a very strong cultural fit,” said Jim Petrilla, Co-Founder and CEO of BioAgilytix.
Read more…
Riverside Partners Invests in BioAgilytix Labs
